• Login
    View Item 
    •   Mak IR Home
    • College of Health Sciences (CHS)
    • School of Medicine (Sch. of Med.)
    • School of Medicine (Sch. of Med.) Collections
    • View Item
    •   Mak IR Home
    • College of Health Sciences (CHS)
    • School of Medicine (Sch. of Med.)
    • School of Medicine (Sch. of Med.) Collections
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    The effect of Kitamine on production of inflammatory markers in post operative patients in Mulago Hospital: A randomized clinical trial.

    Thumbnail
    View/Open
    Masters Thesis (327.4Kb)
    Date
    2011
    Author
    Luggya, Tony Stone
    Metadata
    Show full item record
    Abstract
    BACKGROUND: Mulago hospital provides anaesthesia services for many patients undergoing surgical procedures. Anaesthesia and surgery are associated with immune system response, manifested as an increased pro-inflammatory immune mediator release or increased pain modulation, which may affect or prolong postoperative recovery. Ketamine, a cheap and readily available anaesthetic induction agent, has been reported to have attenuation effects in atopic individuals and asthmatics, and improves paediatric patient outcomes after cardiac surgery. RESEARCH QUESTION: Can 0.5mg/kg of Ketamine given preoperatively have an effect on the post operative levels of pro-inflammatory markers? STUDY OBJECTIVE: To study the effect of, low dose, 0.5mg/kg of Ketamine administered preoperatively on the postoperative pro-inflammatory marker IL-6 and IL-1beta levels, in adult patients undergoing elective surgery in Mulago hospital. STUDY METHOD: A stage 2 phase 4, prospective, randomized, double-blind, placebocontrolled trial was conducted in the main operating theatres of Mulago hospital among patients undergoing elective surgery. 39 patients were recruited and randomized to receive either IV ketamine 0.5 mg/kg or an equal volume of normal saline before induction of anesthesia. Blood samples were taken at baseline before administering intervention, in PACU, 24 and 48 hours post operatively. These determined the IL-1β and IL-6 levels. The study was registered under the clinical trials domain www.clinicaltrials.gov ClinicalTrials.gov Identifier: NCT01339065 RESULTS: Indicated 0.5 mg/kg ketamine given at induction added to Opioid-based anesthesia, suppresses the increase of serum IL-6 at PACU and at 24 hours after surgery. IL-beta was not found in 98% of analyzed samples of the surgical population studied as there was no reaction in the pre-coated ELIZA antibodies micro wells on assay. CONCLUSION: Serum IL-6 levels correlate with patient’s clinical course during and after surgery it is therefore recommended, that in non contraindicated patients, low dose ketamine is beneficial.
    URI
    http://hdl.handle.net/10570/2636
    Collections
    • School of Medicine (Sch. of Med.) Collections

    DSpace 5.8 copyright © Makerere University 
    Contact Us | Send Feedback
    Theme by 
    Atmire NV
     

     

    Browse

    All of Mak IRCommunities & CollectionsTitlesAuthorsBy AdvisorBy Issue DateSubjectsBy TypeThis CollectionTitlesAuthorsBy AdvisorBy Issue DateSubjectsBy Type

    My Account

    LoginRegister

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    DSpace 5.8 copyright © Makerere University 
    Contact Us | Send Feedback
    Theme by 
    Atmire NV